by RSM US LLP | Apr 9, 2024
Insights We are proud to be named a West Coast Regional Leader for 2024 < Back to Insights and Resources Biopharmas: Spending too much on trials, tariffs and indirect taxes?ARTICLE | April 09, 2024Authored by RSM US LLPBiopharmaceutical companies contend with high...
by RSM US LLP | Jan 24, 2024
Insights We are proud to be named a West Coast Regional Leader for 2024 < Back to Insights and Resources With new regulations, medtech companies should assess cyber riskARTICLE | January 24, 2024Authored by RSM US LLPMedtech companies are increasingly grappling...
by RSM US LLP | Jun 23, 2023
Insights We are proud to be named a West Coast Regional Leader for 2024 < Back to Insights and Resources FDA launches new cybersecurity requirements for medical devicesARTICLE | June 23, 2023Authored by RSM US LLPAs medical device technology has become more...
by Vasquez + Company | May 14, 2023
Insights We are proud to be named a West Coast Regional Leader for 2024 Vasquez Advantage Center Request for Additional Information Thank you for your interest in our Vasquez Advantage Center Services. Please fill out the form below to receive additional information....
by RSM US LLP | Apr 7, 2023
Insights We are proud to be named a West Coast Regional Leader for 2024 < Back to Insights and Resources Key trends and business considerations for middle market medtech companiesARTICLE | April 07, 2023Authored by RSM US LLPMiddle market medtech companies have...
Recent Comments